Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects
Sponsor: Intra-Cellular Therapies, Inc.
Summary
The study will be conducted as an open-label and single-center study to evaluate the occupancy of ITI-1284 to the dopamine D2 receptor, serotonin 2A (5-HT2A) receptor, and serotonin transporter (SERT) in healthy subjects.
Official title: An Open-label, Positron Emission Tomography Study to Evaluate Brain Receptor Occupancy, Safety, Tolerability, and Pharmacokinetics After a Single Sublingual Administration of ITI-1284 in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-04-11
Completion Date
2025-09
Last Updated
2025-01-28
Healthy Volunteers
Yes
Conditions
Interventions
ITI-1284 10 mg
ITI-1284 tablet
ITI-1284 20 mg
ITI-1284 tablet
Locations (1)
Clinical Site 1
New Haven, Connecticut, United States